DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

PEG-Intron (Peginterferon Alfa-2B) - Anaemia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Anaemia (322)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include anaemia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 322   Next >>

Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Renal Impairment, Anaemia, Pancreatitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-04-27

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-05-24

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-05-25

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-05-17

Other drugs received by patient: Antebate; Prednisolone; Dexaltin; Ubiron; Aspara CA; Loxonin; Onealfa; Diovan; Berizym (Lysozyme Chloride); Mirobect; Amlodipine; Isoleucine (+) Leucine (+) Valine; Lansoprazole; Mucosta



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.8 microgram per kilogram, qw
    Start date: 2012-05-08

PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-24

PEG-Intron
    Dosage: 1.0 microgram per kilogram, qw
    Start date: 2012-05-01
    End date: 2012-05-01

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-07-12

Other drugs received by patient: Claritin; Ferotym; Livalo; Epadel S



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: White Blood Cell Count Decreased, Renal Impairment, Anaemia, Platelet Count Decreased, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 mcg /kg/week
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-04-25

PEG-Intron
    Dosage: 1.0 mcg /kg/week
    Start date: 2012-06-26

PEG-Intron
    Dosage: 1.0 mcg /kg/week
    Start date: 2012-04-26
    End date: 2012-06-06

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-06-06

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-26

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-06-07

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-06-26
    End date: 2012-07-24

Other drugs received by patient: Motilium; Lorfenamin; Motilium; L Cartin; Rikkunshi-TO; Epadel



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Anaemia, Blood Uric Acid Increased, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 30 microgram per kilogram, qw
    Start date: 2012-07-05

PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-06-21

PEG-Intron
    Dosage: 50 microgram per kilogram, qw
    Start date: 2012-07-12

PEG-Intron
    Dosage: 70 microgram per kilogram, qw
    Start date: 2012-07-19

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-06-27

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-07-05

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-06-27

Other drugs received by patient: Theo-DUR; Lendormin; Mucodyne



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Anaemia, Rash, Haemolytic Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-03-16

PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-03-15

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-04-24
    End date: 2012-05-21

Ribavirin
    Dosage: 500 mg, qd
    Administration route: Oral
    Start date: 2012-05-22

Ribavirin
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-21
    End date: 2012-04-03

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-02-27

Ribavirin
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-02-28
    End date: 2012-03-17

Ribavirin
    Dosage: 300 mg, qd
    Administration route: Oral
    Start date: 2012-04-04
    End date: 2012-04-23

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-03-16

Other drugs received by patient: Coniel; Famotidine; Allopurinol; Celestamine (Betamethasone (+) Dexchlorpheniramine Maleate (+) Fluphen; Isosorbide Dinitrate



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient:

Reactions: White Blood Cell Count Decreased, Contusion, Anaemia, Fall, Loss of Consciousness, Haemoglobin Decreased, Anxiety, Dysgeusia, Urine Uric Acid Increased, Disturbance in Attention, Injury, Feeling Abnormal, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-03

Rebetol
    Dosage: unk unk, qam
    Indication: Hepatitis C
    Start date: 2012-03-03

Rebetol
    Dosage: unk unk, qpm

Rebetol
    Dosage: unk unk, qam

Rebetol
    Dosage: unk unk, qpm
    Start date: 2012-03-03

Rebetol
    Dosage: unk unk, qpm

Rebetol
    Dosage: unk unk, qam

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-31



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Pancreatitis Acute, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-06-15

Rebetol
    Dosage: 800 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-06-20

Telaprevir
    Dosage: 2250 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-06-20

Other drugs received by patient: Talion (Bepotastine Besylate); Feburic; Famostagine D; NEO-Minophagen C; Urdeston; Trebianom; Sitagliptin Phosphate



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-04

PEG-Intron
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-02-08

Ribavirin
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    End date: 2012-02-07

Other drugs received by patient: Lorfenamin; Livalo; Epadel S; Claritin Reditabs; Sodium Ferrous Citrate



Possible PEG-Intron side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient: female

Reactions: Dehydration, Anaemia, Lower Respiratory Tract Inflammation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-02-15

Ribavirin
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-02-15

VX-950
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-15



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-25

Patient:

Reactions: Anaemia, Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-12

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-07-02

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-12
    End date: 2012-07-01

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-12

Other drugs received by patient: Claritin Reditabs Tablets 10 MG; Diltiazem Hydrochloride; Livalo; Epadel S; Ferotym



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-25

Patient:

Reactions: Gastrointestinal Haemorrhage, Anaemia, Haematemesis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2011-11-02
    End date: 2012-06-27

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-02
    End date: 2012-05-28

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-05-29
    End date: 2012-06-30

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Start date: 2012-05-14
    End date: 2012-05-22

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-05-23
    End date: 2012-06-30

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-09
    End date: 2012-05-11



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Pancreatitis Acute, Amylase Increased, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-29

Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-01
    End date: 2012-03-20

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-03-27

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-01-31
    End date: 2012-03-20

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-01-30

Telavic
    Dosage: 2250 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-29

Telavic
    Dosage: 1500 mg, once
    Administration route: Oral
    Start date: 2012-03-01
    End date: 2012-03-20

Telavic
    Dosage: unk

Other drugs received by patient: Glufast; Glufast; Tamiflu; Zantac; Primperan TAB; Tamiflu; Acetaminophen; Zantac



Possible PEG-Intron side effects in 67 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24

Patient: 67 year old female

Reactions: Nausea, Anaemia, Platelet Count Decreased, Blood Creatinine Increased, Hyperuricaemia, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.94 a?g/kg, unk
    Start date: 2012-04-06
    End date: 2012-04-26

PEG-Intron
    Dosage: 1.3 a?g/kg, unk
    Start date: 2012-03-30

PEG-Intron
    Dosage: 1.13 a?g/kg, unk
    Start date: 2012-04-27
    End date: 2012-05-10

PEG-Intron
    Dosage: 1.3 a?g/kg, unk
    Start date: 2012-05-11
    End date: 2012-08-02

PEG-Intron
    Dosage: 1.5 a?g/kg, unk
    Indication: Hepatitis C
    Start date: 2012-02-17
    End date: 2012-03-29

PEG-Intron
    Start date: 2012-05-11

Ribavirin
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-16
    End date: 2012-04-19

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-02-24
    End date: 2012-03-15

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-04-20
    End date: 2012-08-02

Ribavirin
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-17
    End date: 2012-02-23

VX-950
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-03-23
    End date: 2012-04-13

VX-950
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-02-24
    End date: 2012-03-22

VX-950
    Dosage: 2250 mg, qd
    Indication: Hepatitis C
    Start date: 2012-02-17
    End date: 2012-02-23

Other drugs received by patient: Diovan; Urso / 00465701 /; Innolet; Amlodipine



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-13

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-13

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-13

Other drugs received by patient: Ferotym; Epadel S; Livalo; Claritin Reditabs



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-06

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-20

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-06
    End date: 2012-06-19

Telavic
    Dosage: 1500 milligrams, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-06

Other drugs received by patient: Lexotan; Norvasc; Mucosta; Epadel S; Ferotym; Depas; Maglax (Magnesium Oxide); Claritin Reditabs Tablets 10 MG; Livalo



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Renal Disorder, Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-28

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-28
    End date: 2012-05-10

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-05-11
    End date: 2012-05-31

Rebetol
    Dosage: 200 mg, qd
    Start date: 2012-06-01

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-28
    End date: 2012-05-03

Telavic
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2012-06-01
    End date: 2012-06-21

Telavic
    Dosage: 1500 mg, qd
    Start date: 2012-06-22
    End date: 2012-07-20

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-05-04
    End date: 2012-05-31

Other drugs received by patient: Ferotym; Livalo; Epadel S; Claritin Reditabs



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient:

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Confusional State, Tinnitus, Pain, Chills, Anaemia, Hot Flush, Fatigue, Diarrhoea, Depression, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 ?g, qw
    Indication: Hepatitis C
    Start date: 2012-04-27

Ribasphere
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-27

Other drugs received by patient: Prograf



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-24

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, unk
    Indication: Hepatitis C
    Start date: 2012-06-02

Rebetol
    Dosage: stop interval: 2 day
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-02
    End date: 2012-06-14

Rebetol
    Dosage: stop interval: 2 day
    Administration route: Oral
    Start date: 2012-06-15

Telavic
    Dosage: 1000 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-02

Other drugs received by patient: Claritin Reditabs; Omeprazole; Nifedipine; Ferotym; Allopurinol; Benecid; Livalo; Epadel S; Micardis; Onealfa



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-24

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-05-10
    End date: 2012-08-02

Rebetol
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2012-07-06
    End date: 2012-07-22

Rebetol
    Dosage: 600 mg, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-10
    End date: 2012-08-02

Rebetol
    Dosage: 800 mg, qd
    Start date: 2012-07-23
    End date: 2012-08-02

Rebetol
    Dosage: 600 mg, qd
    Start date: 2012-08-14

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-07
    End date: 2012-08-06

Other drugs received by patient: Truvada; Metformin Hydrochloride; Losartan Potassium; Procrit; Ondansetron; Fenofibrate; Isentress; Vitamins (Unspecified); Neupogen



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-08-24

Patient:

Reactions: Weight Decreased, Tongue Disorder, Anaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-04-24
    End date: 2012-01-01

PEG-Intron
    Dosage: 120 microgram, qw
    Start date: 2012-01-01

Rebetol
    Dosage: 2x 200 mg in the morning and 200 mg in the evening
    Start date: 2012-08-09

Rebetol
    Dosage: unk unk, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-24
    End date: 2012-01-01

Rebetol
    Dosage: 600 mg in the morning and 400 mg in the evening
    Administration route: Oral
    Start date: 2012-01-01
    End date: 2012-08-08

Other drugs received by patient: Vasexten; Januvia; Valsartan and Hydrochlorothiazide; Glucophage; Nobiten



Possible PEG-Intron side effects in

Reported by a physician from Argentina on 2012-08-24

Patient:

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Boceprevir
    Dosage: 2400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-07-15
    End date: 2011-01-13

PEG-Intron
    Dosage: 150 units
    Indication: Hepatitis C
    Start date: 2010-07-15
    End date: 2011-01-06

Peginterferon Alfa-2B
    Dosage: 2400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-07-15
    End date: 2011-01-13

Placebo
    Dosage: 2400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-07-15
    End date: 2011-01-13

Ribavirin
    Dosage: 2400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-07-15
    End date: 2011-01-13

Ribavirin
    Dosage: 2400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-07-15
    End date: 2011-01-12

Simvastatin
    Dosage: 2400 mg, unk
    Administration route: Oral
    Start date: 2010-07-15
    End date: 2011-01-13

Simvastatin
    Dosage: 2400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-07-15
    End date: 2011-01-13

Simvastatin
    Dosage: 2400 mg, unk
    Administration route: Oral
    Start date: 2010-07-15
    End date: 2011-01-13

Simvastatin
    Dosage: 2400 mg, unk
    Administration route: Oral
    Start date: 2010-07-15
    End date: 2011-01-13

Simvastatin
    Dosage: 2400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-07-15
    End date: 2011-01-13

Simvastatin
    Dosage: 2400 mg, unk
    Administration route: Oral
    Start date: 2010-07-15
    End date: 2011-01-13



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-24

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 microgram, qw
    Indication: Hepatitis C
    Start date: 2008-02-07
    End date: 2008-06-02

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2008-02-07
    End date: 2008-02-28

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2008-02-29
    End date: 2008-03-06

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2008-03-07



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Anaemia, Hyperuricaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-04-24
    End date: 2012-05-21

PEG-Intron
    Dosage: 1.2 microgram per kilogram, qw
    Start date: 2012-05-22
    End date: 2012-07-16

PEG-Intron
    Dosage: 0.6 microgram per kilogram, qw
    Start date: 2012-07-17

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-24
    End date: 2012-05-01

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-05-04
    End date: 2012-05-14

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-05-02
    End date: 2012-05-03

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-05-15

Telaprevir
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-05-15
    End date: 2012-07-02

Telaprevir
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-07-03
    End date: 2012-07-16

Telaprevir
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-24
    End date: 2012-05-14

Other drugs received by patient: Glyburide; Actos



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Anaemia, Ascites

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-07
    End date: 2012-07-12

PEG-Intron
    Dosage: 50 microgram, qw
    Start date: 2012-07-12
    End date: 2012-07-18

Rebetol
    Dosage: 600 mg, qd (cumulative dose: 8400 mg)
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-07

Rebetol
    Dosage: 400 mg, qd (cumulative dose: 8400 mg)
    Administration route: Oral
    Start date: 2012-07-05
    End date: 2012-07-12

Rebetol
    Dosage: 200 mg, qd (cumulative dose: 8400 mg)
    Administration route: Oral
    Start date: 2012-07-12
    End date: 2012-07-17

Telavic
    Dosage: 1500 mg, qd (cumulative dose: 29250 mg)
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-07-17

Telavic
    Dosage: 2250 mg, qd (cumulative dose: 29250 mg)
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-07
    End date: 2012-06-17

Other drugs received by patient: Motilium; Salagen; Allopurinol; Lansoprazole; Amlodipine; Candesartan Cilexetil



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Renal Disorder, Anaemia

Drug(s) suspected as cause:
Investigational Drug (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-01-16

Investigational Drug (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-10
    End date: 2012-01-13

PEG-Intron
    Dosage: 1.0mcg/kg/week
    Start date: 2012-02-06

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-01-10
    End date: 2012-01-30

PEG-Intron
    Dosage: 1.2mcg/kg/week

PEG-Intron
    Dosage: 1.0mcg/kg/week
    End date: 2012-06-18

Peginterferon Alfa-2B
    Dosage: 1.2 ?g/kg, qw

Peginterferon Alfa-2B
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-01-10
    End date: 2012-01-30

Peginterferon Alfa-2B
    Dosage: 1.0 ?g/kg, qw
    Start date: 2012-02-06

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-03-13

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Start date: 2012-05-21
    End date: 2012-06-18

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Start date: 2012-03-13
    End date: 2012-05-06

Rebetol
    Dosage: 800 mg, once
    Administration route: Oral
    Start date: 2012-05-07
    End date: 2012-05-20

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-10
    End date: 2012-02-12

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-02-13
    End date: 2012-03-12

Telavic
    Dosage: 2250 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-10
    End date: 2012-01-13

Telavic
    Dosage: 1500 mg, once
    Administration route: Oral
    Start date: 2012-01-16

Other drugs received by patient: Epadel; Claritin Reditabs; Sodium Ferrous Citrate; Alenapion; Ferotym; Claritin Reditabs; Singulair; Singulair; Livalo; Livalo; Epadel S; Livalo; Epinastine Hydrochloride



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient:

Reactions: Weight Decreased, non-Consummation, Fatigue, Malaise, RED Blood Cell Count Decreased, White Blood Cell Count Decreased, Vein Disorder, Vomiting, Nausea, Anaemia, Hypoaesthesia, Mental Impairment, Diarrhoea, Alopecia, Feeling Abnormal, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-09-08
    End date: 2012-08-09

Ribavirin
    Dosage: unk unk, unknown
    Start date: 2011-09-08
    End date: 2012-08-09

Other drugs received by patient: Telaprevir



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Brazil on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Oedema Peripheral, Anaemia, Abdominal Distension, Pyrexia, Asthenia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk, qw
    Indication: Hepatitis C
    Start date: 2012-01-02
    End date: 2012-07-25

Ribavirin
    Dosage: unk, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-02
    End date: 2012-07-25



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-23

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-26

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-06-14

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-26

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-26

Other drugs received by patient: Claritin Reditabs Tablets 10 MG; Livalo; Epadel S; Ferotym; Amlodipine Towa



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Weight Decreased, Renal Function Test Abnormal, Alopecia, Haemorrhoids, Anaemia, Urticaria, Vision Blurred, Headache

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 microgram, qw
    Indication: Hepatitis C
    Start date: 2010-10-01

PEG-Intron
    Dosage: 120 unk, unk
    Start date: 2012-06-20
    End date: 2012-08-16

Ribasphere
    Dosage: unk
    Indication: Hepatitis C

Telaprevir
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-13



Possible PEG-Intron side effects in

Reported by a individual with unspecified qualification from United States on 2012-08-23

Patient:

Reactions: Anal Fistula, Anorectal Discomfort, Haemorrhoids, Anaemia, Adverse Event

Adverse event resulted in: disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 microgram, qw
    Start date: 2012-05-25

Ribasphere
    Dosage: 200mg in am 400mg pm

Other drugs received by patient: Procrit; Telaprevir



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014